Company attributes
Location
B2X
0
Number of Employees (Ranges)
1 – 100
Founded Date
2018
0Total Funding Amount (USD)
22,200,000
Latest Funding Round Date
May 30, 2019
Latest Funding Type
Country
We are focused on developing innovative drug productAlthough intended for the lungs, many drugs are not given via the airway because drug properties make it too difficult to formulate for direct to lung delivery.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.